# FDA 483 - Greater Delaware Valley Society of Transplant Surgeons - January 09, 2026

Source: https://www.keypedia.com/records/483/greater-delaware-valley-society-of-transplant-surgeons/86718b99-b335-4578-9127-1971e701c09b

> FDA 483 for Greater Delaware Valley Society of Transplant Surgeons on January 09, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Greater Delaware Valley Society of Transplant Surgeons
- Inspection Date: 2026-01-09
- Product Type: biologics
- Office Name: FDA District Office — Philadelphia, Pennsylvania
- Summary: The FDA issued a Form 483 to Greater Delaware Valley Society of Transplant Surgeons in Philadelphia following an inspection of their HCT/P recovery operations. The inspection revealed deficiencies in procedures for meeting current good tissue practice (CGTP) requirements, specifically concerning cleaning protocols and the use of an expired disinfectant in the operating room. These conditions indicate potential insanitary practices during tissue recovery.

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/emily-a-walters/e80b3581-ffba-4244-9030-b6c9496da932)

Company: https://www.keypedia.com/companies/greater-delaware-valley-society-of-transplant-surgeons/91fa58c7-b4a8-4802-9c6e-ed47c1323fbd

Office: https://www.keypedia.com/offices/fda-district-office-philadelphia-pennsylvania/e70a6e70-40b2-49e4-8360-c3db36c4d2a0